Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.
about
Photodynamic therapy: a new antimicrobial approach to infectious disease?Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer ImmunityVIN usual type-from the past to the futureTherapy of human papillomavirus-related diseaseT-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant LesionsBoosting Tumor-Specific Immunity Using PDTEnhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapyPhotodynamic therapy for localized infections--state of the art.Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesPhase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.Photodynamic therapy for infections: clinical applications.Photodynamic therapy and anti-tumour immunity.The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related moleculesImmune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.Stimulation of anti-tumor immunity by photodynamic therapyPhotodynamic therapy targeted to pathogens.Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease.Photodynamic therapy of cancer: an updateToll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model.Combination approaches to potentiate immune response after photodynamic therapy for cancer.Combination of photodynamic therapy and immunomodulation: current status and future trendsRecent advances in strategies for immunotherapy of human papillomavirus-induced lesions.Photodynamic therapy for treatment of solid tumors--potential and technical challenges.Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future DirectionsAnalysis of the Prevalence of HTLV-1 Proviral DNA in Cervical Smears and Carcinomas from HIV Positive and Negative Kenyan Women.Derivatives of 5-aminolevulinic Acid for photodynamic therapy.Enhancement of anti-tumor immunity by photodynamic therapyOncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Photodynamic therapy enhancement of anti-tumor immunityPhotodynamic therapy-mediated modulation of inflammatory cytokine production by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responsesThe Role of Photodynamic Therapy in the Treatment of Vulvar Intraepithelial Neoplasia.Photodynamic therapy with recombinant adenovirus AdmIL-12 enhances anti-tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model.
P2860
Q24626076-77F692A1-217E-41C3-A6A6-D4F4B908C866Q26797280-5D9AC4BF-E8A4-473E-84F5-1EE6B1C93222Q26865303-33E52908-2D9A-4851-8772-021464B09EC1Q27007473-33C02DB4-E3CB-461D-B1FB-97966742AB30Q27335110-C05B3056-7429-435F-88AA-FF73D388F308Q27692631-98DF3345-9807-47B8-A227-577BEDF2D09CQ28067203-8D999E73-E455-454D-9389-74FB612C100FQ33584715-6B0427AC-DF8A-4CCB-8BAD-7C4FB0AA06FAQ33609755-2913FF7B-6B6C-4D74-8A60-61B0E57D0335Q33664307-02D57454-E4B0-4F94-9F7A-0CC755C69E0DQ33783092-F800E5BE-68C7-4899-A8BD-9DBF72568F4BQ34068214-E68A653B-CB6D-430D-A72C-1B5029A9AA32Q34105703-8E189E7A-9BE3-4110-B6AC-54AE5E8AA7D8Q34128134-C82B11F1-69DA-4019-8193-561E6A6C7A51Q34429312-E8B9B74B-4F58-41DF-A322-EB65223B02A7Q34697795-8647B1C8-EBED-4B38-87EF-CB91FDDEAF12Q34767054-E7170939-FC18-4E9B-A8C9-C2393E83C276Q35123212-0AC3E51F-76F0-45AF-8754-1D57FE026705Q35532394-9A9A3DFD-92CE-44C5-BE05-E65A7264DAD0Q35865283-51342149-1584-428E-B84F-9822A1B9E169Q36253709-70904EDC-11F3-4FEC-AFC5-53BAF382CD18Q36922722-814EB691-5900-4F9F-870D-915F5FB209B6Q36987072-25EABF23-AD70-4DFC-B750-5EF68BD4E8BFQ36995497-35796C62-547D-4601-A2E0-D72DE0ADB05AQ37241539-269D6E09-BD8E-4FE8-A655-592D07DAF60AQ37281763-B54FC6B8-6484-4799-ADDB-4D4EB749CC2EQ37369850-96439105-60F2-435D-BA11-BB1A2B38B81BQ37599675-6F775D03-D9C7-4C20-84DB-C5648CF4D37BQ37676077-2BA77EAE-85B0-4F38-BCFD-BB63EF39ACB7Q37831175-94FA0F9F-3026-480E-9B3F-5B0005DCBDA1Q39026506-290EA26B-039F-42ED-84F3-6F15D311BC82Q42729894-792122F5-9CF4-48A6-B1BD-1D0636BBAA72Q52733994-578DC98B-7F92-4197-8E01-38D1171A78D2Q53543726-4B744910-ABA8-4E86-80E2-4932971E2B47
P2860
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunological and viral factor ...... lasia to photodynamic therapy.
@ast
Immunological and viral factor ...... lasia to photodynamic therapy.
@en
type
label
Immunological and viral factor ...... lasia to photodynamic therapy.
@ast
Immunological and viral factor ...... lasia to photodynamic therapy.
@en
prefLabel
Immunological and viral factor ...... lasia to photodynamic therapy.
@ast
Immunological and viral factor ...... lasia to photodynamic therapy.
@en
P2093
P1433
P1476
Immunological and viral factor ...... lasia to photodynamic therapy.
@en
P2093
Abdel-Hady ES
Duggan-Keen M
Hampson IN
Kitchener HC
Martin-Hirsch P
P304
P407
P577
2001-01-01T00:00:00Z